• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Gastroenterology

Incomplete polyp resection increases risk of future and advanced neoplasia

byHarsh Shah
October 8, 2021
in Gastroenterology, Oncology, Surgery
Reading Time: 2 mins read
Racial differences in colorectal cancer survival linked to health at initial diagnosis
Share on FacebookShare on Twitter

1. Incomplete resection of colon segments was shown to significantly increase the risk of future neoplasia compared to segments with complete resection.

2. Advanced neoplasia was shown to be more likely in incomplete segment resections compared to complete resections.

Evidence Rating Level: 2 (Good)

Study Rundown: An estimated account of incomplete polyp resection occurs for 10% to 30% of all post-colonoscopy colorectal cancer (CRC). However, only indirect evidence is available between incomplete polyp resection and CRC after colonoscopy. As such, this study compared the rate of neoplasia in segments with prior incomplete resection compared to the rate of neoplasia in segments with prior complete resection. Incomplete resection was defined as the presence of neoplastic tissue in any marginal biopsies. The study determined incomplete polyp resection significantly increased the risk of future neoplasia and advanced neoplasia compared to colon segments with complete resection. The observational cohort study was limited by potential patient bias due to incomplete patient follow-up. Nonetheless, this study’s results are significant, and its findings highlight the importance of polypectomy technique to ensure complete resection thereby reducing the risk of future neoplasia.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Rates of incomplete resection of 1- to 20-mm colorectal polyps: a systematic review and meta-analysis

RELATED REPORTS

Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer

2 Minute Medicine Rewind June 29, 2026

2 Minute Medicine Rewind May 25, 2026

In-Depth [prospective cohort]: This observational cohort study enrolled 233 participants across two academic medical centers in the United States. Participants included in the study had resection of a 5- to 20-mm neoplastic polyp, documentation of complete or incomplete resection, and had a surveillance exam. Participants without appropriate documentation or a surveillance exam were excluded from this study. Incomplete resection was defined as the presence of neoplastic tissue in any marginal biopsies. Participants with documented incomplete resection were recommended for a surveillance exam within one year, while participants with a documented complete resection were provided surveillance recommendations based on current guidelines. The primary outcome was the proportion of segments with neoplasia at first surveillance colonoscopy. Of the 233 participants, 166 (71%) participants had at least one surveillance exam by the end of the study. Overall, the median time to surveillance was shorter in the incomplete resection group (median, 17 months; interquartile range, 12 to 47 months) compared to the complete resection group (median, 45 months; interquartile range, 35 to 62 months). In regard to the primary outcome, the risk for neoplasia was significantly greater in the incomplete (52%) group compared to the complete (23%) group (risk difference [RD], 28%; 95% confidence interval [CI], 9% to 47&; P = 0.004). Additionally, participants in the incomplete (18%) group were more likely to have advanced neoplasia compared to the complete (3%) group (RD, 15%; 95% CI, 1% to 29%; P = 0.034). Finally, an incomplete polyp resection was the strongest independent factor associated with neoplasia (odds ratio, 3.0; 95% CI, 1.12 to 8.17). Taken together, incomplete polyp resection was associated with an increased risk of future neoplasia and advanced neoplasia compared to complete resection.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: colorectal cancercomplete resectionincomplete resectionneoplasiapolypectomy
Previous Post

High Amplitude Low Frequency–Music Impulse Stimulation may decrease depressive symptoms in adults with mild-to-moderate depression

Next Post

Statin therapy initiation is associated with diabetes progression

RelatedReports

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening
Chronic Disease

Male sex and hispanic ethnicity are associated with increased risk of early-onset colorectal cancer

June 29, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Wide international variation in survival for periviable neonates
Weekly Rewinds

2 Minute Medicine Rewind May 25, 2026

May 25, 2026
2 Minute Medicine AI Roundup editorial illustration
Oncology

Artificial intelligence predicts colorectal cancer in ulcerative colitis with 99% accuracy

September 4, 2026
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Statin therapy initiation is associated with diabetes progression

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

2 Minute Medicine Rewind, October 12, 2021

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.